Core Insights - The appointment of Dr. Karl Lintner as the Chief Scientific Advisor marks a significant step in the global R&D strategy of the company, enhancing its capabilities in peptide research and development in the beauty industry [1][2][3] Group 1: Dr. Karl Lintner's Background and Role - Dr. Lintner is recognized as a pioneer in peptide technology within the cosmetics industry, having successfully introduced peptide patent technology into cosmetic applications, which transformed global beauty technology [2][3] - His role will include providing forward-looking planning for the company's global peptide technology layout, assisting in building international research cooperation platforms, and integrating global high-quality research resources [6][7] Group 2: Strategic Importance of the Appointment - The collaboration signifies a shift in the Chinese beauty industry towards systematic competitiveness, moving from passive technology acquisition to proactive collaboration with top international scientists [7][8] - The partnership aims to establish a "Chinese Original Ingredient" certification system, enhancing the company's ability to set industry standards and improve its global influence in beauty technology [8] Group 3: Market Context and Opportunities - The Chinese beauty market is experiencing a surge in demand for efficacy-driven products, which aligns with the company's multi-brand strategy and market foundation, positioning it as a strong platform for technological breakthroughs [3][4] - The long-term investment in peptide research by the company has allowed it to catch up with international competitors, establishing a significant presence in the anti-aging segment [5][6]